Why I wouldn’t touch the Centrica share price and its 9% dividend

Does the Centrica plc (LON: CNA) share price collapse mean we should buy the shares, or is it a falling knife to avoid?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Over the past 12 months, the value of Centrica (LSE: CNA) shares has slumped by 30%, and over five years we’ve seen a 66% collapse in the share price.

From 2013 to 2018, earnings per share (EPS) has declined by 57%, and expectations suggest a further drop of 12% this year.

Still not cheap

With that earnings crunch, even those whopping share price falls have still left Centrica on a P/E of around 12 based on 2019 forecasts, and that’s not looking particularly low for a company that’s struggling with the energy price cap and with competition in the industry.

And if that’s not enough, some investors will be keeping well away from Centrica in the fear of the nationalisation that’s threatened under any potential Labour government led by Jeremy Corbyn.

With the share price now at its lowest price this century, do I see a bargain share worth buying? No, I don’t, as I’m really not happy with Centrica’s financial position. In February, with the shares trading at 120p (12% higher than today), I was especially unimpressed by Centrica’s dividend policy, which I described as nonsensical.

Dividends

Forecasts suggest a dividend of 10.5p per share this year, down a bit from last year’s 12p, but it would still yield a massive 9.2%. The problem? It wouldn’t be covered by earnings, just as last year’s wasn’t.

At the last year-end, at 31 December, Centrica’s net debt stood at £2,565m. The company decreed that as within its target range, but for the current year it’s expected to swell to between £3bn and £3.5bn. The adoption of IFRS 16 accounting is apparently part of that, but it’s still a big figure.

The company is still in the process of consolidating its assets to “maintain a strong balance sheet,” but I always thought you had to achieve a strong balance sheet first before you could maintain it. In my view, Centrica’s balance sheet right now is far from strong.

Cash management

I have little confidence in the dividend, and I reckon a cut would be a good thing. In fact, what concerns me is a question that always perplexes me about companies getting into earnings and cash flow squeezes. Why do they take so long to do something about it, and carry on paying big dividends as if everything is rosy?

The Centrica dividend is slated to decline modestly this year and next but I see that as too little, too late. In my view, the best approach for the long-term health of the company would have been to cut the dividend more deeply, by 2017 at the latest.

And I’d like to see companies, perhaps with the exception of those few with enough cash muscle to keep paying through temporary earnings downturns without any harm, to pledge to peg dividends to a minimum level of cover by earnings.

Needs a shakeup

I reckon I’m seeing years of complacency from Centrica, with the company expecting to just carry on carrying on without having to think too much about it.

I’m not saying it’s easy, with the choices basically coming down to retaining profit margins or retaining customers, and Centrica has been losing the latter in large numbers. But I think it needs to resize its expectations.

And I know the right answer for me as an investor — steer clear of Centrica shares.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »